Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Sourya Sourabh Mohakuda"'
Autor:
Rohit Jain, Arun Gopal, Basant Kumar Pathak, Sourya Sourabh Mohakuda, TVSVGK Tilak, Anchit Raj Singh
Publikováno v:
Journal of Laboratory Physicians, Vol 13, Iss 01, Pp 058-063 (2021)
Context Due to the wide spectrum of clinical illness in coronavirus disease 2019 (COVID-19) patients, it is important to stratify patients into severe and nonsevere categories. Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PL
Externí odkaz:
https://doaj.org/article/1e4590a88a6a4d3b9f97e5381edd6567
Autor:
Ankur Nigam, Bhupender Singh, K. Rajesh, Mamta Thawal, Himanshu Sharma, V K Sashindran, Ramanjot Kaur, Sourya Sourabh Mohakuda
Publikováno v:
The American Journal of Managed Care. 27:e338-e342
OBJECTIVES: Nationwide COVID-19 vaccination was initiated in India on January 16, 2021, in a phased manner with vaccines including Covishield. This vaccine was indigenously prepared by Serum Institute of India in line with the Oxford-AstraZeneca ChAd
Autor:
Subramanian Shankar, Sourya Sourabh Mohakuda, Ankit Kumar, P.S. Nazneen, Arun Kumar Yadav, Kaushik Chatterjee, Kaustuv Chatterjee
Publikováno v:
Medical Journal, Armed Forces India
Background Various mathematical models were published to predict the epidemiological consequences of the COVID-19 pandemic. This systematic review has studied the initial epidemiological models. Methods Articles published from January to June 2020 we
Autor:
V K, Sashindran, K Rajesh, Kumar, Ankur, Nigam, Sourya Sourabh, Mohakuda, Navin, Bhati, Debasish, Mohapatra
Publikováno v:
The American journal of managed care. 28(7)
Covishield and Covaxin vaccines have been introduced after rapid approval in India, the nation that has the second most COVID-19 cases globally. These vaccines have been administered in a 2-dose schedule since January 16, 2021. This study deals with
Autor:
Sourya Sourabh Mohakuda, Basant Kumar Pathak, Anchit Raj Singh, Tilak TVSVGK, Prakash Harikrishnan
Publikováno v:
Journal of Marine Medical Society, Vol 22, Iss 3, Pp 83-87 (2020)
The Lens
The Lens
Background: In these desperate times when the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) pandemic has caught the entire world off guard, we have very few evidence-based preventive measures currently available. Various preventive pra
IntroductionCOVISHIELD and COVAXIN have been introduced post rapid approval as COVID vaccines in India, which has the second most COVID cases across countries. These vaccines are being administered in a two-dose schedule from 16 Jan 2021. This study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5eddf1f7d976bf84bad938e2b1621fb8
https://doi.org/10.1101/2021.06.18.21258796
https://doi.org/10.1101/2021.06.18.21258796
Autor:
Sourya Sourabh Mohakuda, Arun Gopal, Anchit Raj Singh, Basant Kumar Pathak, Rohit Jain, Tvsvgk Tilak
Publikováno v:
Journal of Laboratory Physicians
Journal of Laboratory Physicians, Vol 13, Iss 01, Pp 058-063 (2021)
Journal of Laboratory Physicians, Vol 13, Iss 01, Pp 058-063 (2021)
Abstract Context Due to the wide spectrum of clinical illness in coronavirus disease 2019 (COVID-19) patients, it is important to stratify patients into severe and nonsevere categories. Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte
Publikováno v:
International Journal of Clinical Endocrinology and Metabolism. 6:008-010
Fibrodysplasia Ossificans Progressiva is a rare (incidence-one in two million people3) and disabling genetic condition, diagnosis of which is generally based on presence of congenital abnormality of great toes, progressive heterotopic ossification an
Publikováno v:
International Journal of Clinical Endocrinology and Metabolism. 6:005-007
Post prandial hypoglycemia refers to low blood glucose levels in the post meal period. In absence of any gastro-intestinal abnormality or surgery, other less common conditions need consideration. Extended glucose tolerance test helps confirm the diag